Accolade (NASDAQ:ACCD) Price Target Cut to $8.00

Accolade (NASDAQ:ACCD – Free Report) had its price objective reduced by Stifel Nicolaus from $13.00 to $8.00 in a report published on Friday, Benzinga reports. They currently have a buy rating on the stock. Several other research firms have also weighed in on ACCD. Barclays reduced their target price on Accolade from $11.00 to $5.50 […]

Leave a Reply

Your email address will not be published.

Previous post Biogen (NASDAQ:BIIB) Earns “Buy” Rating from Needham & Company LLC
Next post Ardelyx (NASDAQ:ARDX) Cut to “Sell” at StockNews.com